Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Elborn

Showing results (231-240 of 270) with videos related to

Pageof 27
Sort By:
Thorax|February 1, 2018
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injuryAlastair Proudfoot, Andrew Bayliffe, Cecilia M O'Kane, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2017
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary diseaseAlison J Dicker, Megan L Crichton, Eleanor G Pumphrey, et al.
Respiratory Medicine|December 6, 2024
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasisZina Alfahl, Gisli G Einarsson, J Stuart Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
Mycoses|April 28, 2018
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosisAlireza Abdolrasouli, Amelia C Bercusson, Johanna L Rhodes, et al.
The European Respiratory Journal|January 19, 2019
Targeting of cathepsin S reduces cystic fibrosis-like lung diseaseDonna M Small, Ryan R Brown, Declan F Doherty, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
Trials|December 21, 2019
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trialJudy Martina Bradley, Rohan Anand, Brenda O'Neill, et al.
The European Respiratory Journal|July 15, 2017
Characterisation of eppin function: expression and activity in the lungAaron Scott, Arlene Glasgow, Donna Small, et al.
The European Respiratory Journal|June 28, 2018
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite studyMarianne S Muhlebach, Joseph E Hatch, Gisli G Einarsson, et al.
Pageof 27

Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
Thorax|February 1, 2018
Novel anti-tumour necrosis factor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation in experimental acute lung injuryAlastair Proudfoot, Andrew Bayliffe, Cecilia M O'Kane, et al.
The Journal of Allergy and Clinical Immunology|May 17, 2017
Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary diseaseAlison J Dicker, Megan L Crichton, Eleanor G Pumphrey, et al.
Respiratory Medicine|December 6, 2024
Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasisZina Alfahl, Gisli G Einarsson, J Stuart Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
Mycoses|April 28, 2018
Airway persistence by the emerging multi-azole-resistant Rasamsonia argillacea complex in cystic fibrosisAlireza Abdolrasouli, Amelia C Bercusson, Johanna L Rhodes, et al.
The European Respiratory Journal|January 19, 2019
Targeting of cathepsin S reduces cystic fibrosis-like lung diseaseDonna M Small, Ryan R Brown, Declan F Doherty, et al.
Physiological Genomics|December 24, 2009
EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severityRebecca Darrah, Edward McKone, Clare O'Connor, et al.
Trials|December 21, 2019
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trialJudy Martina Bradley, Rohan Anand, Brenda O'Neill, et al.
The European Respiratory Journal|July 15, 2017
Characterisation of eppin function: expression and activity in the lungAaron Scott, Arlene Glasgow, Donna Small, et al.
The European Respiratory Journal|June 28, 2018
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite studyMarianne S Muhlebach, Joseph E Hatch, Gisli G Einarsson, et al.
Pageof 27